drugset / Trial / NCT00974571

Montelukast in Perennial Allergic Rhinitis - 2001-2002 Study (0476-246)

NCT00974571

Phase 3 Completed 1365 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will assess the ability of montelukast to improve the signs and symptoms of perennial allergic rhinitis compared to placebo. Cetirizine is included in the study as an active control.

Timeline

Start
2001-11
Primary completion
2002-05
Completion
2002-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cetirizine Other / unclassified 10 mg Oral
Subject Montelukast Other / unclassified 10 mg Oral